Lorenzo A Calò

InstitutionUniversity of Padova
AddressPadova
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 11 Covid-19 publications, with a maximum of 2 publications in May 2020 and July 2020 and August 2020 and May 2021
    All Publications
    Bar chart showing 151 publications over 20 distinct years, with a maximum of 15 publications in 2006
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Qassim L, Cirella I, Baboci G, Rossi B, Bonfante L, Calò LA. Padova University nephrology unit's peritoneal dialysis management during the COVID-19 pandemic. Clin Nephrol. 2021 Jul; 96(1):60-62. PMID: 33797394.
      Citations:    Fields:    Translation:Humans
    2. Calò LA, Rigato M, Sgarabotto L, Gianesello L, Bertoldi G, Ravarotto V, Davis PA. ACE2 and SARS-CoV-2 Infection Risk: Insights From Patients With Two Rare Genetic Tubulopathies, Gitelman's and Bartter's Syndromes. Front Med (Lausanne). 2021; 8:647319. PMID: 34017843.
      Citations: 1     
    3. Davis PA, Bertoldi G, Calò LA. On the imbalanced protective arm of RAS in COVID-19: Lesson from rare genetic tubulopathies. Int J Clin Pract. 2021 May; 75(5):e14075. PMID: 33887873.
      Citations:    Fields:    Translation:Humans
    4. Dian S, Simeone M, Rossi B, Scaparrotta G, Fragasso A, Carretta G, Capizzi A, Donato D, Cianci V, Cattelan AM, Calò LA. Going to war with COVID-19: Strategies for SARS-CoV-2 management in the Padua Nephrology and Dialysis Unit's hemodialysis facility. Clin Nephrol. 2021 Mar; 95(3):151-156. PMID: 33250072.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    5. Calò LA, Davis PA. Far di Necessità Virtù, using rare tubulopathies, Gitelman's and Bartter's syndromes, to inform the fight against COVID-19. J Nephrol. 2021 04; 34(2):281-283. PMID: 33387334.
      Citations:    Fields:    Translation:HumansPHPublic Health
    6. Calò LA, Davis PA. Are the Clinical Presentations (Phenotypes) of Gitelman's and Bartter's Syndromes Gene Mutations Driven by Their Effects on Intracellular pH, Their "pH" Enotype? Int J Mol Sci. 2020 Aug 07; 21(16). PMID: 32784543.
      Citations: 5     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    7. Bertoldi G, Gianesello L, Calò LA. Letter: ACE2, Rho kinase inhibition and the potential role of vitamin D against COVID-19. Aliment Pharmacol Ther. 2020 Aug; 52(3):577-578. PMID: 32656827.
      Citations: 2     Fields:    
    8. Calò LA, Davis PA, Rigato M, Sgarabotto L. ACE2 and prognosis of COVID-19: Insights from Bartter's and Gitelman's syndromes patients. J Med Virol. 2020 11; 92(11):2308-2309. PMID: 32374416.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    9. Calò LA, Davis PA, Rigato M, Sgarabotto L. Angiotensin-converting enzyme inhibitors, angiotensin II type 1 receptor blockers and risk of COVID 19: information from Bartter's and Gitelman's syndromes patients. J Hypertens. 2020 07; 38(7):1386. PMID: 32502097.
      Citations: 3     Fields:    
    10. Nalesso F, Garzotto F, Cattarin L, Gobbi L, Qassim L, Sgarabotto L, Tiberio I, Calò LA. A Continuous Renal Replacement Therapy Protocol for Patients with Acute Kidney Injury in Intensive Care Unit with COVID-19. J Clin Med. 2020 May 19; 9(5). PMID: 32438617.
      Citations: 2     
    11. Calò LA, Bertoldi G, Davis PA. Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter's and Gitelman's syndrome patients. Pharmacol Res. 2020 08; 158:104903. PMID: 32430287.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    Calò's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (155)
    Explore
    _
    Co-Authors (26)
    Explore
    _
    Similar People (60)
    Explore
    _